Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
AngioDynamics (ANGO) Stock Price & Analysis
205 Followers
ANGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.26 - $11.38
Previous Close$6.33
Volume490.69K
Average Volume (3M)524.43K
Market Cap
$253.55M
Enterprise Value$175.09M
Total Cash (Recent Filing)$78.45M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.3
Beta0.44
Next Earnings
Jul 10, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.78
Shares Outstanding40,054,533
10 Day Avg. Volume966,450
30 Day Avg. Volume524,428
Standard Deviation0.13
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.90
Price to Sales (P/S)3.37
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda-1.69
Forecast
1Y Price Target
$14.67Price Target Upside131.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
AngioDynamics News
PremiumCompany Announcements
AngioDynamics Unveils Financial Outlook and Growth Plans
Bulls Say, Bears Say
Bulls Say
Financial PerformanceActual total revenue was $75.2M, beating projections, indicating a strong performance for the company.
Regulatory MilestoneFDA clearance for AlphaVac MMA F18 for treatment of pulmonary embolism expands the product's market reach, potentially driving up future sales.
Strategic FocusThe divestiture allows the company to concentrate its efforts on the high-growth potential of its Med Tech portfolio, which can lead to increased profitability.
Bears Say
Financial PerformanceNet loss was significantly higher primarily due to goodwill impairment and litigation settlement.
Legal IssuesNet loss was $190.4M due to goodwill impairment and settlement of litigation.
Revenue ImpactDivestiture and discontinuation of certain product lines will reduce future revenue by approximately $50M.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ANGO FAQ
What was AngioDynamics’s price range in the past 12 months?
AngioDynamics lowest stock price was $5.26 and its highest was $11.38 in the past 12 months.
What is AngioDynamics’s market cap?
Currently, no data Available
When is AngioDynamics’s upcoming earnings report date?
AngioDynamics’s upcoming earnings report date is Jul 10, 2024 which is in 82 days.
How were AngioDynamics’s earnings last quarter?
AngioDynamics released its earnings results on Apr 04, 2024. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.155 by -$0.005.
Is AngioDynamics overvalued?
According to Wall Street analysts AngioDynamics’s price is currently Undervalued.
Does AngioDynamics pay dividends?
AngioDynamics does not currently pay dividends.
What is AngioDynamics’s EPS estimate?
AngioDynamics’s EPS estimate is -$0.16.
How many shares outstanding does AngioDynamics have?
AngioDynamics has 40,054,530 shares outstanding.
What happened to AngioDynamics’s price movement after its last earnings report?
AngioDynamics reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.155. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of AngioDynamics?
Among the largest hedge funds holding AngioDynamics’s share is Western Standard Llc. It holds AngioDynamics’s shares valued at 419K.
---
AngioDynamics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.67 (131.75% Upside)
$14.67 (131.75% Upside)
Blogger Sentiment
Bearish
ANGO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 80.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $67.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 6.0%
Last 30 Days ▲ 13.6%
Last 30 Days ▲ 13.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.28%
12-Months-Change
Fundamentals
Return on Equity
-62.42%
Trailing 12-Months
Asset Growth
-40.16%
Trailing 12-Months
Company Description
AngioDynamics
AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.
---
ANGO Company Deck
---
ANGO Earnings Call
Q3 2024
0:00 / 0:00
---
ANGO Stock 12 Months Forecast
Average Price Target
$14.67
▲(131.75% Upside)
Technical Analysis
Best Analysts Covering ANGO
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-4.52%
reiterated a buy rating 14 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -4.52% per trade.
---